Cargando…

In silico design of quadruplex aptamers against the spike protein of SARS-CoV-2

Nucleic acid aptamers are short sequences of nucleic acid ligands that bind to a specific target molecule. Aptamers are experimentally nominated using the well-designed SELEX (systematic evolution of ligands by exponential enrichment) method. Here, we designed a new method for diagnosis and blocking...

Descripción completa

Detalles Bibliográficos
Autores principales:	Behbahani, Mandana, Mohabatkar, Hassan, Hosseini, Barumand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514331/ https://www.ncbi.nlm.nih.gov/pubmed/34664030 http://dx.doi.org/10.1016/j.imu.2021.100757

Ejemplares similares

Investigating the anti-streptococcal biofilm effect of ssDNA aptamer-silver nanoparticles complex on a titanium-based substrate
por: Hosseini, Barumand, et al.
Publicado: (2022)

Analysis and comparison of physiochemical properties, mutations and glycosylation patterns between RNA polymerase and membrane protein of SARS-CoV and SARS-CoV-2
por: Behbahani, Mandana, et al.
Publicado: (2021)

In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein
por: Behbahani, Mandana, et al.
Publicado: (2021)

Predicting Promiscuous T Cell Epitopes for Designing a Vaccine Against Streptococcus pyogenes
por: Ebrahimi, Samira, et al.
Publicado: (2018)

In silico comparison of Iranian HIV -1 envelop glycoprotein with five nearby countries
por: Ghafari, Maryam, et al.
Publicado: (2016)

Anticancer activity of cow, sheep, goat, mare, donkey and camel milks and their caseins and whey proteins and in silico comparison of the caseins
por: Shariatikia, Malihe, et al.
Publicado: (2017)

Towards the first multi-epitope recombinant vaccine against Crimean-Congo hemorrhagic fever virus: A computer-aided vaccine design approach
por: Nosrati, Mokhtar, et al.
Publicado: (2019)

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
por: Lin, Yu-Chao, et al.
Publicado: (2022)

Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study
por: Devi, Arpita, et al.
Publicado: (2021)

A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2
por: Gupta, Ankit, et al.
Publicado: (2021)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
por: Etemadi, Ali, et al.
Publicado: (2022)

DNA aptamer selection for SARS-CoV-2 spike glycoprotein detection
por: Martínez-Roque, Mateo Alejandro, et al.
Publicado: (2022)

De novo ssRNA Aptamers against the SARS-CoV-2 Main Protease: In Silico Design and Molecular Dynamics Simulation
por: Morena, Francesco, et al.
Publicado: (2021)

Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen
por: Svobodova, Marketa, et al.
Publicado: (2021)

Studying the effects of several heat-inactivated bacteria on colon and breast cancer cells
por: Rabiei, Parisa, et al.
Publicado: (2019)

Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis
por: Dar, Hamza Arshad, et al.
Publicado: (2020)

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2
por: Cleri, Fabrizio, et al.
Publicado: (2021)

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1
por: Yang, Ge, et al.
Publicado: (2021)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein
por: Kathwate, Gunderao H.
Publicado: (2022)

An In Silico Design of Peptides Targeting the S1/S2 Cleavage Site of the SARS-CoV-2 Spike Protein
por: Ho, Chian, et al.
Publicado: (2023)

Identifying epitopes for cluster of differentiation and design of new peptides inhibitors against human SARS-CoV-2 spike RBD by an in-silico approach
por: Akachar, Jihane, et al.
Publicado: (2020)

In silico direct folding of thrombin-binding aptamer G-quadruplex at all-atom level
por: Yang, Changwon, et al.
Publicado: (2017)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants
por: Haseeb, Muhammad, et al.
Publicado: (2023)

Rapid and Efficient Detection of the SARS-CoV-2 Spike Protein Using an Electrochemical Aptamer-Based Sensor
por: Idili, Andrea, et al.
Publicado: (2021)

A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern
por: Zhang, Zijie, et al.
Publicado: (2022)

Development of high affinity broadly reactive aptamers for spike protein of multiple SARS-CoV-2 variants
por: Le, Thao T., et al.
Publicado: (2023)

In silico design of refined ferritin-SARS-CoV-2 glyco-RBD nanoparticle vaccine
por: Masoomi Nomandan, Seyedeh Zeinab, et al.
Publicado: (2022)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

Design and identification of novel annomontine analogues against SARS-CoV-2: An in-silico approach
por: Waidha, Kamran, et al.
Publicado: (2021)

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
por: Durojaye, Olanrewaju Ayodeji, et al.
Publicado: (2020)

Repurposing of SARS-CoV nucleocapsid protein specific nuclease resistant RNA aptamer for therapeutics against SARS-CoV-2
por: Parashar, Nidarshana Chaturvedi, et al.
Publicado: (2020)

In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2
por: Siddiqa, M A., et al.
Publicado: (2021)

In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein
por: Kiran, Gangarapu, et al.
Publicado: (2022)

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach
por: Behera, Santosh Kumar, et al.
Publicado: (2021)

A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism
por: Schmitz, Anton, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1rgv2v33b4ssr5dcpt0nqotorf